BridgeBio Pharma

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$2,168
$211,120
$1,745
$4,091
Gross Profit
296
209,226
1,147
3,493
EBITDA
-171,074
5,339
-169,229
-157,692
EBIT
-172,648
3,743
-170,814
-159,331
Net Income
-73,456
-35,216
-168,148
-176,999
Net Change In Cash
2,168
211,120
1,745
4,091
Free Cash Flow
72,256
-221,029
-125,254
-145,657
Cash
547,367
475,353
375,935
505,213
Basic Shares
187,586
178,705
174,462
163,308

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$9,303
$77,648
$69,716
$8,249
Gross Profit
6,857
74,214
66,602
5,161
EBITDA
-574,642
-353,678
-539,676
-468,833
EBIT
-581,136
-360,449
-545,519
-471,921
Net Income
-643,202
-493,964
-639,297
-483,925
Net Change In Cash
9,303
77,648
69,716
8,249
Cost of Revenue
20,519
37,686
-5,518
Free Cash Flow
-529,026
-425,815
-546,180
-407,232
Cash
375,935
376,689
393,772
356,082
Basic Shares
162,791
147,473
144,356
117,995

Earnings Calls

Quarter EPS
2024-06-30
-$0.39
2024-03-31
-$0.20
2023-12-31
-$0.96
2023-09-30
-$1.08